Rodney Young
2022 - RAPT Therapeutics
In 2022, Rodney Young earned a total compensation of $1.5M as Chief Financial Officer at RAPT Therapeutics, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $956,415 |
| Salary | $435,000 |
| Total | $1,541,415 |
Young received $956.4K in option awards, accounting for 62% of the total pay in 2022.
Young also received $150K in non-equity incentive plan and $435K in salary.
Rankings
In 2022, Rodney Young's compensation ranked 2,165th out of 5,694 executives tracked by ExecPay. In other words, Young earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,165 out of 5,694 | 62nd |
Division Manufacturing | 1,163 out of 3,099 | 63rd |
Major group Chemicals And Allied Products | 499 out of 1,406 | 65th |
Industry group Drugs | 459 out of 1,307 | 65th |
Industry Pharmaceutical Preparations | 333 out of 953 | 65th |
Source: SEC filing on April 7, 2023.
Young's colleagues
We found two more compensation records of executives who worked with Rodney Young at RAPT Therapeutics in 2022.